What is the pathophysiology of immune reconstitution inflammatory syndrome (IRIS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Pathophysiology of Immune Reconstitution Inflammatory Syndrome (IRIS)

IRIS results from a dysregulated inflammatory response when recovering CD4+ T cells encounter high pathogen or antigen burden in patients initiating antiretroviral therapy at low CD4 counts, leading to excessive activation of both innate and adaptive immune systems that paradoxically worsens clinical status despite effective viral suppression. 1

Two Distinct Pathophysiologic Mechanisms

IRIS manifests through two phenomena that share common underlying mechanisms 1:

1. Unmasking IRIS

  • Previously subclinical opportunistic infections become clinically apparent after ART initiation
  • Common pathogens: disseminated MAC, tuberculosis, CMV retinitis, Pneumocystis pneumonia, Kaposi sarcoma 1
  • The recovering immune system "unmasks" infections that were present but not generating sufficient inflammation to cause symptoms

2. Paradoxical IRIS

  • Clinical worsening of a known, treated opportunistic infection after ART initiation 1
  • Occurs despite appropriate pathogen-specific therapy
  • Represents exaggerated inflammatory response to residual antigens

Core Pathophysiologic Mechanisms

The Innate-Adaptive Immune Dysregulation

The fundamental problem is hyper-responsiveness of the innate immune system to reconstituting T cell help, rather than simple T cell recovery alone 2. This involves:

  • Pre-ART priming: High pathogen burden excessively primes innate immune cells (macrophages, dendritic cells) before T cell reconstitution 3
  • Failure of pathogen clearance: Defective phagocyte function allows persistent high antigenic load, which becomes the substrate for inflammation 4
  • Lymphopenia-induced proliferation: Rapid T cell expansion in a systemically activated, antigen-rich environment 4

CD4+ T Cell Dysfunction

The reconstituting T cell response is qualitatively abnormal 4, 5:

  • Th1/Th17 bias: Exaggerated pro-inflammatory T cell responses, particularly prominent in TB-IRIS 5, 6
  • Th2 skewing pre-ART: Many patients exhibit Th2-dominant, low-inflammatory states before ART that shift dramatically 6
  • Regulatory T cell failure: Defective Treg function fails to control the inflammatory response 4
  • Non-pathogen-specific activation: Self-antigen-specific T cells can also drive IRIS, not just pathogen-specific cells 3

IL-7 and Immune Reconstitution

  • Increased IL-7 availability during lymphopenia drives rapid T cell expansion 4, 6
  • This expansion occurs in the context of high antigen burden and systemic immune activation
  • Creates conditions for disproportionate inflammatory responses

Chemokine-Mediated Trafficking

  • CXCR3+ and CCR5+ effector T cells traffic to sites of antigen deposition 6
  • Elevated chemokines (IP-10, interferon-γ) guide inflammatory cells to tissues 5
  • Results in localized, tissue-destructive inflammation

Clinical Implications of Pathophysiology

IRIS causes considerable morbidity and occasional mortality 1, particularly with:

  • Tuberculosis-associated IRIS
  • Cryptococcal IRIS (especially CNS involvement) 1, 6

Critical Risk Factors Derived from Pathophysiology

  • Low baseline CD4 count (<50 cells/μL): Greater degree of immune dysregulation 7
  • High pathogen burden: More antigen to drive inflammation 4, 7
  • Rapid viral suppression: Faster immune reconstitution 7
  • Early ART initiation after OI diagnosis: Less time for pathogen clearance before immune recovery 7

Biomarkers Reflecting Pathophysiology

Elevated inflammatory markers predict or diagnose IRIS 5:

  • C-reactive protein
  • Interferon-inducible protein 10 (IP-10)
  • Interferon-γ
  • Pro-inflammatory cytokines and chemokines

These markers are elevated even before ART in unmasking IRIS cases, indicating pre-existing immune priming 5.

Beyond HIV: IRIS in Other Immunocompromised States

The same pathophysiologic principles apply to non-HIV IRIS 8, 9:

  • Post-chemotherapy neutrophil recovery
  • Post-transplant immunosuppression withdrawal
  • Rapid corticosteroid taper

This confirms that the core mechanism is immune reconstitution encountering high antigen burden, regardless of the cause of initial immunosuppression 8.

Key Clinical Pitfall

The paradox of IRIS is that appropriate treatment (ART, pathogen-specific therapy) triggers clinical deterioration 1, 2. Clinicians must distinguish IRIS from treatment failure, new infections, or drug toxicity—a diagnostic challenge that requires understanding the underlying inflammatory pathophysiology rather than assuming therapeutic failure.

References

Research

[Immune reconstitution inflammatory syndrome associated with invasive pulmonary fungal disease].

Zhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.